Boosting the Fight Against Childhood Cancer with AI
Shares of Tempus AI rose following the executive order promoting the use of AI to develop solutions for pediatric cancer.
Shares of Tempus AI rose following the executive order promoting the use of AI to develop solutions for pediatric cancer.
Tempus AI's FDA-cleared Pixel update uses AI to analyze heart MRI scans, generating detailed tissue maps to detect hidden issues like fibrosis, helping doctors provide more precise, personalized care.